No Prescription |
 |
 | ||
|
Lipitor Generic Atorvastatin |
|
| ||
No Prescription » Prescription Drugs 10 » Lipitor Generic Atorvastatin Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Lowering high cholesterol and triglycerides in certain patients. It also increases high-density lipoprotein (HDL "good") cholesterol levels. It is used along with an appropriate diet. It is used in certain patients to reduce the risk of heart attack stroke chest pain caused by angina or blood vessel blockage. It is also used in certain patients to reduce the risk of hospitalization for congestive heart failure or the need for medical procedures to open blocked heart blood vessels. It may also be used for other conditions as determined by your doctor.Lipitor is an HMG-CoA reductase inhibitor also known as a "statin." It works by reducing the production of certain fatty substances in the body including cholesterol.Atorvastatin is a cholesterol-lowering medication that blocks the production of cholesterol (a type of fat) in the body.Atorvastatin reduces low-density lipoprotein (LDL) cholesterol and total cholesterol in the blood. Lowering your cholesterol can help prevent heart disease and hardening of the arteries conditions that can lead to heart attack stroke and vascular disease.Atorvastatin is used to treat high cholesterol. Atorvastatin is also used to lower the risk of stroke heart attack or other heart complications in people with coronary heart disease or type 2 diabetes.Your doctor may prescribe it along with a special diet if your blood cholesterol or triglyceride level is high and you have been unable to lower your readings by diet alone. The drug works by helping to clear harmful low-density lipoprotein (LDL) cholesterol out of the blood and by limiting the body's ability to form new LDL cholesterol.Your doctor may prescribe Lipitor to reduce your chances of having a heart attack or developing heart disease if you have any of the following risk factors:Are age 55 years or older. Smoke. Have high blood pressure. Have low levels of HDL (high-density lipoprotein--the good cholesterol). Have a family history of early heart disease. For people at high risk of heart disease the doctor may suggest a cholesterol-lowering medication if LDL readings are 130 or more. For those at low risk a medication is considered at readings of 190 or more. Buy Lipitor Generic Atorvastatin and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Lipitor Generic Atorvastatin: Product Type: Prescription Drugs 10 Lipitor ( Generic Atorvastatin ) Lipitor (Generic Atorvastatin) Generic Atorvastatin 10mg Generic Atorvastatin Lipitor
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
